Trace element imbalances in blood serum of Alzheimer’s disease patients
- 30 June 2021
- journal article
- research article
- Published by Taylor & Francis in Spectroscopy Letters
- Vol. 54 (6) , 458-471
Abstract
Trace element concentration of blood serum samples of patients afflicted with Alzheimer’s disease and controls were determined using inductively coupled plasma-mass spectrometry. 22 elements starting from low atomic number element lithium to high atomic number element lead were covered under this study. The concentration of lithium and vanadium were measured for the first time. The concentration levels of lithium, aluminum, vanadium, chromium, manganese, iron, cobalt, nickel, zinc, arsenic, selenium, silver, cadmium, cesium, mercury, and lead are found to be higher and the concentration levels of gallium, rubidium, and barium to be lower in the samples of the Alzheimer’s disease afflicted patients compared to controls. The difference in the concentration levels of beryllium, copper, and strontium between the specimens of Alzheimer's disease patients and controls is statistically insignificant. An attempt is made to correlate the trace element imbalance, where observed, with the etiology and pathogenesis of Alzheimer’s disease.Keywords
This publication has 67 references indexed in Scilit:
- Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive abilityBioMetals, 2009
- Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: Relevance to etiopathogenesis of Parkinson's diseaseToxicology and Applied Pharmacology, 2009
- Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Role of Proteolytic Activation of Protein Kinase Cδ in Oxidative Stress-Induced ApoptosisAntioxidants & Redox Signaling, 2003
- Increased blood mercury levels in patients with Alzheimer's diseaseJournal of Neural Transmission, 1998
- CAN THE CONTROVERSY OF THE ROLE OF ALUMINUM IN ALZHEIMER'S DISEASE BE RESOLVED? WHAT ARE THE SUGGESTED APPROACHES TO THIS CONTROVERSY AND METHODOLOGICAL ISSUES TO BE CONSIDERED?Journal of Toxicology and Environmental Health, 1996
- Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's diseaseArchives of Gerontology and Geriatrics, 1995
- A POSSIBLE ROLE OF ZINC IN THE PATHOLOGY OF DEMENTIAThe Lancet, 1981